Moreover, we demonstrated that the combined inhibition of redox APE1 and STAT3, using APX2009 and Stattic, respectively, was more effective in decreasing the viability of MDA‐MB‐231 and MCF‐7 breast cancer cells than the individual treatment, highlighting a synergistic effect between these two compounds. The gene discussed is STAT3; the disease is breast carcinoma.